Japanese pathologists and cardiologists from the prestigious Nagano Red Cross Hospital, Shinshu University School of Medicine, Joetsu General Hospital, and the National Institute of Infectious Diseases of Japan, have reported in the peer-reviewed international journal, Pathology International, about the clinical case study of the death of a 61-year-old woman, otherwise healthy, after receiving the mRNA vaccine against SARS-CoV-2. The death was by myocarditis, usually a fate reserved for the vaccinated young. The article raised concern, given the acknowledgment of the novelty of the mRNA vaccine— “the first applied nucleic acid vaccine for humans,” with an “unclear” mechanism of efficacy and immune acquisition. Japan has been much more scientific in their approach to Covid than the blind faith, if not dog-like obedience, that the West has placed in Big Pharma.